Fidelity Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Fidelity Investments’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-627,363	Closed	-$1.97M	–	2741
2016 Q3	$1.97M	Hold	627,363	–	–	﹤0.01%	2370
2016 Q2	$3.22M	Hold	627,363	–	–	﹤0.01%	2274
2016 Q1	$2.57M	Hold	627,363	–	–	﹤0.01%	2327
2015 Q4	$5.09M	Sell	627,363 -189,219	-23%	-$1.58M	﹤0.01%	2189
2015 Q3	$6.89M	Hold	816,582	–	–	﹤0.01%	2077
2015 Q2	$7.68M	Sell	816,582 -78,179	-9%	-$728K	﹤0.01%	2112
2015 Q1	$8.29M	Sell	894,761 -209,010	-19%	-$2M	﹤0.01%	2067
2014 Q4	$10.2M	Sell	1,103,771 -85,100	-7%	-$716K	﹤0.01%	1988
2014 Q3	$10.6M	Sell	1,188,871 -489,452	-29%	-$3.56M	﹤0.01%	1989
2014 Q2	$13.2M	Buy	1,678,323 +162,311	+11%	+$1.23M	﹤0.01%	1966
2014 Q1	$12M	Buy	1,516,012 +1,209,600	+395%	+$9.73M	﹤0.01%	1959
2013 Q4	$1.93M	Buy	306,412 +131,300	+75%	+$688K	﹤0.01%	2353
2013 Q3	$623K	Buy	175,112 +22,200	+15%	+$50.5K	﹤0.01%	2492
2013 Q2	$297K	Buy	+152,912	New	+$307K	﹤0.01%	2515

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments's CORV Position: Q4 2016 in Review

Fidelity Investments sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2016, closing a stake of 627,363 shares — an estimated $1.97M sold.

Fidelity Investments first reported a position in CORV in Q2 2013 and held it in 14 quarters. The position peaked at $13.2M in Q2 2014. 35 funds tracked by Wall St. Rank hold CORV as of Q4 2016.

Fidelity Investments reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2016 after selling out during the quarter.
Fidelity Investments sold 627,363 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2016, an estimated $1.97M.
Fidelity Investments first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 14 quarters.
Fidelity Investments's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $13.2M in Q2 2014.
35 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2016.

Based on Fidelity Investments's 13F filing for Q4 2016, filed 10 Feb 2017.